207940.KS
207940.KS- Latest Trade
- trading higher--
- Change
- --
- % Change
- --
- Day Range
- -- - --
- 52-Week Range
- -- - --
As of May 22 2022. Values delayed up to 15 minutes
About
Company Information
Samsung Biologics Co Ltd is a Korea-based company primarily engaged in development, manufacture and distribution of biological products. The Company, as a contract manufacturing organization (CMO), mainly develops and manufactures antibody drugs used for treatment of cancer, autoimmune disease, diabetes and chronic diseases. It also provides cell line development and process development services. The Company distributes its products in domestic and overseas markets.
Address
300, Songdo bio-daero, Yeonsu-guINCHEON,
21987
South Korea
Industry
Biotechnology & Drugs
Executive Leadership
- John Rim
- Co-President, Chief Executive Officer, Director
- Tae Han Kim
- Co-President, Director
- Dong Jung Kim
- Vice President, Director
- Pierre Catignol
- Vice President
- James Choi
- Vice President
- Yong Sin Kim
- Vice President
- Sam Machour
- Vice President
- Gyun Noh
- Vice President
- James Park
- Vice President
- Ho Yeol Yoon
- Vice President
- Yeong Jin Cho
- Assistant Managing Director
- Jobes Depraitas
- Assistant Managing Director
- Keith Ellis
- Assistant Managing Director
- Do Yeong Huh
- Assistant Managing Director
- Yong Hwan Jin
- Assistant Managing Director
- Ja Hun Kang
- Assistant Managing Director
- Chang Suk Kim
- Assistant Managing Director
- Gi Jung Kim
- Assistant Managing Director
- Hui Jeong Kim
- Assistant Managing Director
- Chung Wu Lee
- Assistant Managing Director
- Jae Seon Lee
- Assistant Managing Director
- Sang Yun Lee
- Assistant Managing Director
- Hyeong Wu Moon
- Assistant Managing Director
- Se Gang Park
- Assistant Managing Director
- Yong Park
- Assistant Managing Director
- Sang Won Seo
- Assistant Managing Director
- Kevin Sharp
- Assistant Managing Director
- Byung Hwa Shim
- Assistant Managing Director
- Daniel Slone
- Assistant Managing Director
- Eun Yeong Yang
- Assistant Managing Director
- Hui Gyun Yim
- Assistant Managing Director
- Sun Jo Gwon
- Non-Executive Independent Director
- Geun Nyeong Huh
- Non-Executive Independent Director
- Seok Wu Jung
- Non-Executive Independent Director
- Gyeong Hui Kim
- Non-Executive Independent Director
Latest News
- MarketsS.Korea stocks recover as LG Energy, Samsung Biologics shine
Round-up of South Korean financial markets:
- MarketsDeals of the day Mergers and acquisitions
The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Friday:
- MarketsS.Korean shares rebound as Samsung Elec earnings boost chip sector
Round-up of South Korean financial markets:
- MarketsDeals of the day Mergers and acquisitions
The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Thursday:
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,841.80 | -- |
| Copper | 772.55 | 0.46%Positive |
| Brent Crude Oil | 112.55 | -- |
| CBOT Soybeans | 1,705.25 | -- |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 3,901.36 | 0.01%Positive |
| Euro STOXX 50 | 3,657.03 | 0.45%Positive |
| FTSE 100 | 7,389.98 | 1.19%Positive |
| Nikkei 225 | 26,739.03 | 1.27%Positive |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes